Exendin-4 Regulatory Approval

In-Depth Look: The World of Exendin-4 Regulatory Approval

exendin 4

List of Approved Drug Products containing exendin 4 in the FDA Orange Book on PharmaCompass.com. Find drug product details including manufacturer information, dosage form, strength, approval status, application number, and regulatory data.

Illustration of Exendin-4 Regulatory Approval
Exendin-4 Regulatory Approval

Furthermore, visual representations like the one above help us fully grasp the concept of Exendin-4 Regulatory Approval.

Regulatory Approvals /Commerical Initially developed by Amylin Pharmaceuticals, Exenatide was approved by the US FDA in April 2005 with the commercial name Byetta.

Exendin-4 Regulatory Approval photo
Exendin-4 Regulatory Approval

Egan and her collaborators later found that exendin-4 increased insulin production and protected the insulin-producing cells against damage in humans, and that its effects lasted for hours. After further clinical testing, it was deemed to be safe and effective, and it received FDA approval in 2005. But the story doesn't end there.

📁 Category: Approval

Visual Collection